Episode

Depression and Metabolism: What This New Study Reveals

Podcast
Metabolic Mind
Published
Mar 23, 2026
Duration seconds
2007
Processing state
not_requested
Canonical source
https://metabolicmind.org/
Audio
https://episodes.captivate.fm/episode/1729b9eb-3b68-41d2-b460-229f60dc4bda.mp3
JSON
/v1/public/podcasts/metabolic-mind-6253550/episodes/depression-and-metabolism-what-this-new-study-reveals
Markdown
/podcast/metabolic-mind-6253550/depression-and-metabolism-what-this-new-study-reveals.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/metabolic-mind-6253550/episodes/depression-and-metabolism-what-this-new-study-reveals/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/metabolic-mind-6253550/depression-and-metabolism-what-this-new-study-reveals.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this special episode of Metabolic Mind, Dr. Julie Milder, Director of Neuroscience at Baszucki Group, speaks with Dr. Fabiano Gomes, psychiatrist and researcher at McMaster University, and the inaugural recipient of the Baszucki Group Metabolic Psychiatry Scholar Award. Dr. Gomes recently published a pilot feasibility trial of a ketogenic diet for depression in the Journal of Affective Disorders. In this conversation, he shares how the study came together, what the results revealed, and why metabolic approaches may offer new hope for people struggling with treatment-resistant depression. In this episode, they discuss: The pilot ketogenic diet trial for depression and its key findings How the study successfully transitioned to a fully remote clinical trial during COVID What the results suggest about feasibility, adherence, and clinical improvements The role of nutritional ketosis in mood disorders and metabolic psychiatry Dr. Gomes’ vision for launching a Metabolic Psychiatry Clinic in Canada Plans to integrate biomarkers, brain imaging, and real-world clinical care The importance of training clinicians and dietitians to expand access to metabolic therapies Dr. Gomes’s work represents an exciting step forward in the growing field of metabolic psychiatry, which explores how metabolism and brain energy may influence conditions like depression, bipolar disorder, and other mental health disorders. The conversation also highlights the importance of building clinical infrastructure and training programs to make metabolic therapies more accessible to patients today. 💡Learn more about the growing research on metabolic psychiatry and depression on our Depression Topic Page: https://www.metabolicmind.org/resources/topics/keto-for-depression/ 👍 If you found this discussion help…